CA2233935A1 - Procede d'isolement d'immunoglobuline a partir de petit lait - Google Patents

Procede d'isolement d'immunoglobuline a partir de petit lait Download PDF

Info

Publication number
CA2233935A1
CA2233935A1 CA002233935A CA2233935A CA2233935A1 CA 2233935 A1 CA2233935 A1 CA 2233935A1 CA 002233935 A CA002233935 A CA 002233935A CA 2233935 A CA2233935 A CA 2233935A CA 2233935 A1 CA2233935 A1 CA 2233935A1
Authority
CA
Canada
Prior art keywords
cfa
immunoglobulin
whey
antigen
milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002233935A
Other languages
English (en)
Inventor
Joseph H. Crabb
Elizabeth A. Acker
Frank E. Ruch
Daniel J. Freedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immucell Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/539,539 external-priority patent/US5747031A/en
Application filed by Individual filed Critical Individual
Publication of CA2233935A1 publication Critical patent/CA2233935A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002Coronaviridae
    • C07K16/1003Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2 or Covid-19]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1239Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Vibrionaceae (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention porte sur procédé d'isolement d'immunoglobuline à partir de petit lait ou de petit lait concentré et sur un concentré d'immunoglobuline hautement purifié. Ledit procédé consiste en une co-précipitation des lipides et des protéines différentes de l'immunoglobuline, et d'un polymère portant des charges et d'un acide gras.
CA002233935A 1995-10-05 1996-10-04 Procede d'isolement d'immunoglobuline a partir de petit lait Abandoned CA2233935A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/539,539 US5747031A (en) 1995-10-05 1995-10-05 Process for isolating immunoglobulins in whey
US62327696A 1996-03-28 1996-03-28
US08/623,276 1996-03-28
US08/539,539 1996-03-28

Publications (1)

Publication Number Publication Date
CA2233935A1 true CA2233935A1 (fr) 1997-04-10

Family

ID=27066118

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002233935A Abandoned CA2233935A1 (fr) 1995-10-05 1996-10-04 Procede d'isolement d'immunoglobuline a partir de petit lait

Country Status (5)

Country Link
EP (1) EP0859783A1 (fr)
JP (1) JPH11512746A (fr)
AU (1) AU7256596A (fr)
CA (1) CA2233935A1 (fr)
WO (1) WO1997012901A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055502A1 (fr) * 2001-12-24 2003-07-10 Fonterra Co-Operative Group Limited Composition d'immunoglobuline
US8211476B2 (en) 2003-03-14 2012-07-03 Meiji Co., Ltd. Compositions against rotavirus infection and processes for producing the same
CA2609173C (fr) * 2005-05-24 2015-03-17 The United States Of America As Represented By The Secretary Of The Navy Naval Medical Research Center, Code 00L Produit immunoprophylactique passif a base d'adhesine fimbriale anti-adhhesine 5
US20120101262A1 (en) * 2009-06-25 2012-04-26 Bristol-Myers Squibb Company Protein purification by caprylic acid (octanoic acid) precipitation
WO2013037718A1 (fr) 2011-09-12 2013-03-21 Scandinavian Biopharma Holding Ab Procédé d'augmentation de la présentation de l'antigène etec cs6 sur la surface cellulaire et produits pouvant être ainsi obtenus
WO2016073401A1 (fr) 2014-11-03 2016-05-12 Bristol-Myers Squibb Company Utilisation de la précipitation d'acide caprylique pour la purification de protéines
FR3076294B1 (fr) 2017-12-29 2022-01-28 Lab Francais Du Fractionnement Procede de purification d'anticorps a partir de lait brut
WO2020053661A1 (fr) * 2018-09-13 2020-03-19 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Procédés de purification d'anticorps émanant du lait de mammifères non humains transgéniques comprenant l'utilisation de chitosane
CN111718410B (zh) * 2020-06-05 2022-10-11 江南大学 一种制备卵黄免疫球蛋白的方法
WO2022118114A1 (fr) * 2020-12-04 2022-06-09 3M Innovative Properties Company Unité de filtration et procédé de purification de biomatériau
CN114014926B (zh) * 2021-11-20 2023-08-18 江苏天美健大自然生物工程有限公司 一种简单快速从牛初乳中制备高纯度免疫球蛋白g1和g2的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
FR2657612A1 (fr) * 1990-02-01 1991-08-02 Armines Procede d'extraction et/ou de prepurification selective de proteines contenues dans des produits lactes.

Also Published As

Publication number Publication date
AU7256596A (en) 1997-04-28
WO1997012901A1 (fr) 1997-04-10
JPH11512746A (ja) 1999-11-02
EP0859783A1 (fr) 1998-08-26

Similar Documents

Publication Publication Date Title
Mietens et al. Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins
US4284623A (en) Method of treating inflammation using bovine milk
CA1340183C (fr) Fraction de lactoserum immunologiquement active et methode d'obtention
US5017372A (en) Method of producing antibody-fortified dry whey
Mehra et al. Milk immunoglobulins for health promotion
EP0152270B1 (fr) Méthode d'immunisation passive de mammifères à l'aide d'anticorps aviaires et/ou bovins et compositions à cet usage
AU667533B2 (en) Monospecific polyclonal antibodies to shiga-like toxins
CA2260007C (fr) Procede pour prevenir, contrer, ou reduire les lesions gastro-intestinales
JP2002501526A (ja) 乳汁における免疫グロブリンaの生成方法
FI98269C (fi) Menetelmä olennaisesti puhtaan tulehdusta estävän tekijän eristämiseksi maidosta
US5106618A (en) Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
CA2233935A1 (fr) Procede d'isolement d'immunoglobuline a partir de petit lait
CA2357685A1 (fr) Composition de facteur de transfert et methode de production de cette composition
JP4316012B2 (ja) 卵の抗炎症性組成物、単離法および使用
EP0484148A1 (fr) Procédé de préparation d'un médicament pour à la fois, le traitement et la prévention d'ulcères peptiques gastriques et de la gastrite, et des médicaments ainsi formulés
US5747031A (en) Process for isolating immunoglobulins in whey
US20020009429A1 (en) Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
Boesman-Finkelstein et al. Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes
WO1999002188A1 (fr) Anticorps de jaune d'oeuf de poule, diriges contre les antigenes de clostridium difficile et leur utilisation dans le traitement de la colite pseudomembraneuse
JPH04275232A (ja) 胃炎,胃または十二指腸潰瘍予防食品
US5198215A (en) Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
US10478493B2 (en) Method of treating protozoal gastrointestinal disorders in immunocompromised patients
JP2001502309A (ja) 溶血性尿毒性症候群を予防するための経口投与薬剤を製造するために免疫グロブリン製剤を使用する方法
AU608619B2 (en) Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
WO1992002538A1 (fr) Produit et procede de transfert de constituants de prevention de maladies derives du colostrum a travers les voies gastro-intestinales

Legal Events

Date Code Title Description
FZDE Discontinued